OCDX News and Press, Ortho Clinical Diagnostics plc From 03/23/21

Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data PR Newswire RARITAN, N.J. , March 23, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one ...

Gainers: Clovis Oncology (CLVS) +43%, Marker Therapeutics (MRKR) +23%, Alector (ALEC) +17%, Aravive (ARAV) +14%, Ortho Clinical Diagnostics (OCDX) +8%.Losers: Idera Pharmaceuticals (IDRA) -62%, Praxis Precision Medicines (PRAX) -13%,  Acu...

RARITAN, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), please note that in the last sentence of the first paragraph under the “Fourth Quarter 2020 Operational Highlights&#x...

Ortho Clinical Diagnostics (OCDX): Q4 GAAP EPS of -$0.28 misses by $0.09.Revenue of $516.6M (+9.1% Y/Y) beats by $9.18M.Fourth quarter Adjusted EBITDA of $133.6 million represented a 3.5% increase. Adjusted free cash flow rose 185.1% to $101.5 year over year.Company is providing 2021 guidance...

RARITAN, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world's largest pure-play in-vitro diagnostics (IVD) companies, today announced financial results for the fourth quarter and fiscal year ended January 3, 2021. Fourth...

Ortho's New COVID-19 Total and IgG Antibody Tests Receive CE Mark for Semi-Quantitative Results - Ortho's new VITROS® Anti-SARS-CoV-2 Total 2 Antibody assay and VITROS® Anti-SARS-CoV-2 IgG 2 Antibody assay receive CE Mark - Both tests can aid in identifying individ...

RARITAN, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care, today announced it will report results for the fourth quarter an...

RARITAN, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient care, today announced that Evelyn Dilsaver, former CEO of Charles Schwab Inv...

A number of Wall Street firms, including Bank of America, J.P. Morgan, Citi, and Credit Suisse have initiated shares of Ortho Clinical Diagnostics Holdings plc (OCDX) with buy or overweight ratings.Bank of America analyst Derik de Bruin, who has a $23 price target on shares, says the company ...

Ortho Clinical Diagnostics ([[OCDX]] +3.1%) looks set to end the five-day losing streak after a string of positive sell-side remarks today.The analysts from Citi, Piper Sandler, BofA, Morgan Stanley, and JPMorgan have all initiated the coverage on the stock with buy-equivalent ratings. The pr...